Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. optonmda

OptoNMDA

Optical strategies to investigate NMDA receptor functional diversity and its therapeutic potential

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 OptoNMDA project word cloud

Explore the words cloud of the OptoNMDA project. It provides you a very rough idea of what is the project "OptoNMDA" about.

excitatory    deleterious    glun2a    neuronal    physiological    glutamate    genetic    active    ing    pathologies    form    genes    hypo    nmdar    stroke    therapeutic    light    sites    signalling    receptor    function    synapses    glun2    dysregulation    optonmda    glun2b    convertible    mental    precise    transmission    configuration    proposes    tetramers    subunit    manipulation    plasticity    preparations    derivatives    schizophrenia    subtypes    modulating    class    inactive    circuit    competitive    play    subunits    roles    manner    mammalian    ex    selectively    neurotransmitter    site    anatomical    orthosteric    usually    retardation    allosteric    nmda    allostery    isomerize    receptors    innovative    optical    vivo    temporal    tools    glun1    critical    generally    spatio    polyamine    pharmacological    pathology    containing    brain    reversibly    nmdars    population    photo    functional    physiology    synaptic    strategies    lacking    fundamental    counteract    models    biophysical    individual    compounds    consists    encoded    opto    gated    act   

Project "OptoNMDA" data sheet

The following table provides information about the project.

Coordinator		 INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE 

Organization address
address: RUE DE TOLBIAC 101
city: PARIS
postcode: 75654
website: www.inserm.fr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country France [FR]
 Project website http://www.mony.fr/optoNMDA.shtml
 Total cost 185˙076 €
 EC max contribution 185˙076 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2015
 Funding Scheme MSCA-IF-EF-RI
 Starting year 2016
 Duration (year-month-day) from 2016-04-01   to  2018-07-21

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) coordinator 115˙672.00
2    ECOLE NORMALE SUPERIEURE FR (PARIS CEDEX 05) participant 69˙403.00

Map

 Project objective

NMDA receptors (NMDARs) form a class of receptors gated by glutamate, the major neurotransmitter in the mammalian brain. These receptors play fundamental roles in synaptic transmission and plasticity. They are also involved in numerous pathologies including stroke, mental retardation or schizophrenia. NMDARs are thus targets of strong therapeutic interest. NMDARs are tetramers usually composed of two GluN1 and two GluN2 subunits encoded by four different genes (GluN2A-D), resulting in a large number of receptor subtypes having distinct anatomical, biophysical, pharmacological and signalling properties. Understanding the functional role of these individual subtypes in the brain is of great importance to develop new strategies to counteract the deleterious effects of NMDAR dysregulation. However, tools allowing targeting of a specific population of NMDARs in a given neuronal circuit are currently lacking. The OptoNMDA research programme proposes the development of an innovative optical approach to selectively enhance the activity of NMDARs containing the GluN2B subunit (GluN2B-NMDARs) in ex vivo and in vivo preparations. This approach consists in developing photo-convertible polyamine derivatives that can reversibly isomerize between an inactive and active configuration with light to act on the GluN2B-NMDAR polyamine allosteric modulating site in a precise spatio-temporal manner (opto-allostery). I will study the physiological and potential therapeutic roles of these compounds by testing their effects on synaptic transmission and plasticity and on genetic models of NMDAR hypo-function. Compared to previous studies targeting orthosteric (competitive) sites, the opto-allostery approach will allow manipulation of NMDARs in a more specific and physiological manner. This project should thus provide critical novel information on NMDARs, and more generally, on the physiology and pathology of excitatory synapses.

 Publications

year authors and title journal last update
List of publications.
2018 Viktoria Klippenstein, Laetitia Mony, Pierre Paoletti
Probing Ion Channel Structure and Function Using Light-Sensitive Amino Acids
published pages: 436-451, ISSN: 0968-0004, DOI: 10.1016/j.tibs.2018.02.012 		Trends in Biochemical Sciences 43/6 2019-07-26

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OPTONMDA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "OPTONMDA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

CONDISOBS (2020)

Contain, Distribute, Obstruct. Governing the Mobility of Asylum Seekers in the European Union

Read More  

Mel.Photo.Protect (2019)

Unraveling the Photoprotecting Mechanism of Melanin - From a Library of Fragments to Simulation of Spectra and Function

Read More  

PHOTOCYLINDER (2019)

Photodynamic therapy enabled DNA-fork-binding metallo-cylinders: drugs and release triggers

Read More